Advance Search
WANG Mingming, YANG Ying, ZHAO Jinrong, ZHU Changde. Effect of combined therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease combined with phlegm turbidity and qi deficiency as well as blood stasis syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(18): 38-41, 59. DOI: 10.7619/jcmp.20210720
Citation: WANG Mingming, YANG Ying, ZHAO Jinrong, ZHU Changde. Effect of combined therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease combined with phlegm turbidity and qi deficiency as well as blood stasis syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(18): 38-41, 59. DOI: 10.7619/jcmp.20210720
shu

Effect of combined therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease combined with phlegm turbidity and qi deficiency as well as blood stasis syndrome

  • 1.

    Department of Rehabilitation, Suzhou High-tech People's Hospital of Jiangsu Provice, Suzhou, Jiangsu, 215129

  • 2.

    Department of Traditional Chinese Medicine, Suzhou High-tech People's Hospital of Jiangsu Provice, Suzhou, Jiangsu, 215129

More Information
  • Received Date: February 21, 2021
  • Available Online: October 19, 2021
  • Published Date: September 27, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the clinical effect of Yiqi Huoxue Huatan Decoction combined with acupoint catgut embedding in the treatment of acute exacerbation of chronic obstructive pulmonary disease combined with phlegm turbidity and qi deficiency as well as blood stasis syndrome.
      Methods  A total of 185 patients with acute exacerbation of chronic obstructive pulmonary disease combined with turbidity of phlegm as well as qi deficiency and blood stasis syndrome were randomly divided into group A (conventional western medicine treatment), group B (conventional western medicine treatment combined with Yiqi Huoxue Huatan Decoction), group C (conventional western medicine treatment combined with acupoint catenary embedding) and group D (conventional western medicine treatment combined with Yiqi Huoxue Huatan Decoction and acupoint catenary embedding). TCM symptom score, forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), ratio of FEV1 to FVC (FEV1/FVC) and clinical efficacy were compared among the four groups. The changes of inflammatory cytokine levels[interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α)] and hemorheological indexes[whole blood viscosity, plasma viscosity, plasma fibrinogen (FIB)] were observed before and after treatment.
      Results  The scores of cough, expectoration, wheezing and chest tightness and total scores of TCM symptoms in the D group after treatment were significantly lower than those in the A group, B group and C group (P < 0.05). The FEV1, FVC, FEV1/FVC and the total effective rate of the D group after treatment were higher than those of the A group, B group and C group (P < 0.05 or P < 0.01). The serum IL-6, IL-8 and TNF-α levels and whole blood viscosity, plasma viscosity and plasma fibrinogen (FIB) levels in the D group after treatment were lower than those in the A group, B group and C group (P < 0.05).
      Conclusion  Yiqi Huoxue Huatan Decoction combined with acupoint catgut embedding can significantly reduce the clinical symptoms and inflammatory reaction, improve lung function and hemorheology, and enhance clinical efficacy of acute exacerbation of chronic obstructive pulmonary disease patients combined with phlegm turbidity combined and qi deficiency as well as blood stasis syndrome.
    • FullText(HTML)
    • References (14)
  • [1]
    JONES S E, BARKER R E, NOLAN C M, et al. Pulmonary rehabilitation in patients with an acute exacerbation of chronic obstructive pulmonary disease[J]. J Thorac Dis, 2018, 10(Suppl 12): S1390-S1399. http://www.onacademic.com/detail/journal_1000041678585799_883d.html
    [2]
    王世强, 张弘, 楼黎明, 等. 穴位埋线结合适时御邪方案对COPD稳定期患者疗效评价及炎症的影响[J]. 中华全科医学, 2017, 15(2): 328-330. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201702044.htm
    [3]
    陈炜, 张念志, 张一萌, 等. 益气活血化痰汤对慢性阻塞性肺疾病大鼠HIF-1α、IL-17A表达影响研究[J]. 辽宁中医药大学学报, 2017, 19(3): 25-27. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201703009.htm
    [4]
    李复红. 现代临床慢性阻塞性肺疾病[M]. 天津: 天津科学技术出版社, 2013: 21-22.
    [5]
    郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 54-57.
    [6]
    潘小丹, 范良, 卢保强, 等. 加味小青龙汤合膀胱经姜疗治疗外寒内饮型慢性阻塞性肺疾病急性加重期临床研究[J]. 中国中医药信息杂志, 2018, 25(3): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYY201803008.htm
    [7]
    唐燕. 慢性阻塞性肺炎急性加重期辩证治疗的疗效及影响因素分析[J]. 实用临床医药杂志, 2017, 21(9): 39-41, 56. doi: 10.7619/jcmp.201709010
    [8]
    刘建媛, 胡小梅, 王建国, 等. 化痰行瘀通腑汤保留灌肠对慢性阻塞性肺疾病急性加重期患者肺功能及炎症因子的影响[J]. 中国中医药信息杂志, 2019, 26(4): 24-28. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYY201904006.htm
    [9]
    董良杰, 刘豹, 释延琳, 等. 参芪补肺汤联合八段锦治疗稳定期气阴两虚型慢性阻塞性肺疾病[J]. 中医学报, 2018, 33(12): 2309-2312. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201812007.htm
    [10]
    靳娜, 孟德维, 杜晓. 黄芪多糖对COPD大鼠炎症反应和肺功能的影响[J]. 中国中医急症, 2018, 27(8): 1399-1402. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ201808023.htm
    [11]
    褚旭, 刘晓菊, 邱敬满, 等. 党参多糖对细颗粒物所致慢性阻塞性肺疾病小鼠肺泡巨噬细胞吞噬功能障碍加剧的抑制作用[J]. 中华医学杂志, 2016, 96(14): 1134-1138.
    [12]
    邱超, 郄增旺, 程凤宽, 等. 复方当归注射液穴位注射配合刺络法治疗慢阻肺临床疗效及肺循环功能的观察[J]. 河北中医药学报, 2011, 26(1): 25-26, 37. https://www.cnki.com.cn/Article/CJFDTOTAL-HZYX201101019.htm
    [13]
    鲁良, 刘宏平. 丹参川穹注射液对下肢骨折术后血液流变学及炎性因子的影响[J]. 西南国防医药, 2018, 28(5): 56-58. https://www.cnki.com.cn/Article/CJFDTOTAL-XNGF201805021.htm
    [14]
    李连珍, 宋宁, 王宪龄. 牡丹皮清热凉血活血消痈作用机制研究[J]. 中华中医药学刊, 2014, 32(4): 863-865. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201404056.htm
    • Related Articles

  • Related Articles

    [1]HUANG Minjie, XU Junwei, HE Qifang, WANG Linlin, WANG Meng. Clinical value of detection of B-type natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease combined with right heart failure[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 101-105, 111. DOI: 10.7619/jcmp.20244017
    [2]LI Yan, HAN Li. Relationships of serum levels of B-type natriuretic peptide and insulin-like growth factor binding protein-3 with atrial fibrillation in patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 101-105,109. DOI: 10.7619/jcmp.20234044
    [3]WEN Lu, OUYANG Hui, YUAN Hao, TIAN Jing, ZHANG Fang. Application of B-type brain natriuretic peptide in patients with acute exacerbation of chronic obstructive pulmonary disease with left ventricular ejection fraction retention[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 46-50. DOI: 10.7619/jcmp.20222662
    [4]GUO Yulian. Effect of furosemide combined with levosimendan on cardiac function and N-terminal B-type natriuretic peptide in patients with refractory heart failure[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 47-49. DOI: 10.7619/jcmp.202018013
    [5]ZHANG Liwei. Correlations between serum uric acid, N-terminal pro-B-type natriuretic peptide, vasostatin-2 and left ventricular ejection fraction in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 29-31. DOI: 10.7619/jcmp.202012008
    [6]CHEN Gang. Correlation between resting heart rate and serum high sensitive C reactive protein, brain natriuretic peptide and left ventricular ejection fraction in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 31-33, 36. DOI: 10.7619/jcmp.201924010
    [7]GAO Zhangdai, WU Bin, QI Lijun, ZHENG Xiyuan. Relationship between serum B-type natriuretic peptide, D-dimer, C reactive protein and short-termprognosis in patients with massive cerebral infarction in subacute phase[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 32-35. DOI: 10.7619/jcmp.201914008
    [8]GU Jiayun, XIA Hailian, WANG Fangfang, ZHOU Yang, LIU Pei, TENG Yan. Expressions and significance of peripheral galectin-3 and N-terminal B-type brain natriuretic peptide in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2017, (5): 26-28,35. DOI: 10.7619/jcmp.201705007
    [9]HUA Can, ZHU Xiaofa, MA Lu, WANG Hongyan, BIAN Ning, REN Bingwen. Study on correlation between global registry of acute coronary events, B-type natriuretic peptide and coronary artery disease in senile patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (9): 13-15. DOI: 10.7619/jcmp.201309004
    [10]JIN Hong, ZHAO Ping. Influences of meglumine adenosine cyclophosphate on the heart function and B-type natriuretic peptide of senile patients with heart failure[J]. Journal of Clinical Medicine in Practice, 2013, (1): 78-80. DOI: 10.7619/jcmp.201301025

Catalog

    Get Citation
    PDF
    XML
    Article views (188) PDF downloads (11) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return